Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 3/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 3/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL789807 | 0.85 | KIF11 (0.39) | PIM1PIM2ALDH1A1GAA | |
| SCHEMBL10227108 | 0.80 | KIF11 (0.50) | PIM1PIM2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL4549314 | 0.78 | MCL1 (0.33) | PIM1PIM2ALDH1A1MCL1 | |
| SCHEMBL21677455 | 0.77 | GAA (0.46) | SCN10AUSP2ALDH1A1GAAPKM | |
| SCHEMBL8281206 | 0.76 | NPC1 (0.38) | USP2ALDH1A1GAAHPGDALOX15 | |
| SCHEMBL15746946 | 0.75 | ALDH1A1 (0.31) | SCN10AUSP2ALDH1A1GAAPKM | |
| SCHEMBL889804 | 0.73 | HPGD (0.41) | ALDH1A1HPGDHSD17B10MCL1 | |
| SCHEMBL788687 | 0.73 | KIF11 (0.41) | PIM1PIM2ALDH1A1GAAHPGD | |
| SCHEMBL9603912 | 0.73 | NPC1 (0.40) | ALDH1A1GAAHPGDHSD17B10 | |
| SCHEMBL10227371 | 0.72 | RAB9A (0.35) | PIM1PIM2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9450188-B2 | Carbazole derivative, light-emitting element material and organic semiconductor material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20140145175-A1 | Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-29 | — | — | US | disclosed |
| US-8642782-B2 | Carbazole derivative, light-emitting element material and organic semiconductor material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-02-04 | — | — | US | disclosed |
| US-20120071668-A1 | Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071668-A1 | Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material | SLC39A3, SULT1A1, NUTF2 | PIM1 3603/4885PIM2 3428/4885SCN10A 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.